Product logins

Find logins to all Clarivate products below.


Dialysis Access Treatment Devices | Market Insights | Europe | 2022

The COVID-19 pandemic has had a negative impact on the European dialysis access treatment device market in 2020 and to some extent in 2021. Once the market stabilizes, the dynamic nature of the market, the launch of novel and innovative premium-price products backed by clinical data, and improvement in reimbursement will lead to steady growth through the remainder of forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints in the region.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…